期刊文献+

蛋白冠与纳米粒子的相互作用 被引量:2

Interaction between Protein Corona and Nanoparticles
原文传递
导出
摘要 近年来,尽管纳米粒子在生物医学领域的研究中取得了巨大的进展,但很少能进入临床试验阶段,其中,很大程度取决于人们缺乏对纳米粒子与生理环境之间相互作用的认知,对纳米粒子进入体内后的生物学特性了解有限。在生理环境下,蛋白质会吸附于纳米粒子表面,从而形成蛋白冠,这种纳米粒子-蛋白冠复合物的形成严重影响纳米粒子的生物学特性,限制了纳米粒子的临床应用,因此,蛋白质与纳米粒子之间的相互作用应该被深入研究。目前,对纳米粒子-蛋白冠复合物的研究属于一个相对较新的研究领域。概括了蛋白冠的研究现状,对蛋白冠与纳米粒子相互作用所产生的影响进行了重点阐述,也介绍了预防和减少蛋白冠形成的方法,为纳米粒子的进一步研发提供了思路。 In recent years,although nanoparticles have made great progress in biomedical research,they rarely enter clinical trials.This is mainly due to the lack of understanding of the interaction between nanoparticles and the physiological environment and the limited understanding of the biological characteristics of nanoparticles after they enter the body.In the physiological environment,proteins adsorb on the surface of nanoparticles and form protein corona.The formation of this nanoparticles-protein corona complex seriously affects the biological characteristics of nanoparticles and restricts the clinical application of nanoparticles.Therefore,the interaction between protein corona and nanoparticles should be further studied.At present,the research on nanoparticle-protein corona complex is a relatively new field.This review summarizes the research status of protein corona,and focuses on the impact of the interaction between protein corona and nanoparticles.It also introduces methods to prevent and reduce the formation of protein corona,providing ideas for further research and development of nanoparticles.
作者 褚宇琦 陆飞妃 刘洋 何芳 王大壮 陈立江 CHU Yu-qi;LU Fei-fei;LIU Yang;HE Fang;WANG Da-zhuang;CHEN Li-jiang(School of Pharmaceutical Sciences,Liaoning University,Shenyang 110036,China)
机构地区 辽宁大学药学院
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2020年第4期78-83,共6页 China Biotechnology
基金 辽宁省教育厅创新人才支持计划(LR2017065)资助项目.
关键词 蛋白冠 纳米粒子 相互作用 Protein corona Nanoparticles Interaction
  • 相关文献

参考文献1

二级参考文献34

  • 1Sund, J.; Alenius, H.; Vippola, M.; Savolainen, K.; Puustinen, A. Proteomic characterization of engineered nanomaterial- protein interactions in relation to surface reactivity. ACS Nano 2011, 5, 4300-4309.
  • 2Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.; Cingolani, R.; Pompa, P. P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 2010, 4, 7481-7491.
  • 3Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105, 14265-14270.
  • 4Ferreira, S. A.; Oslakovic, C.; Cukalevski, R.; Frohm, B.; Dahlback, B.; Linse, S.; Gama, F. M.; Cedervall, T. Biocompatibility of mannan nanogel-safe interaction with plasma proteins. Biochim. Biophys. Acta 2012, 1820, 1043- 1051.
  • 5Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnology, Biology, and Medicine 2009, 5, 106-117.
  • 6Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the uanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proe. Natl. Acad. Sei. USA 2007, 104, 2050-2055.
  • 7Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem., Int. Ed. 2007, 46, 5754--5756.
  • 8Walkey, C. D.; Olsen, J. B.; Guo, H.; Emili, A.; Chan, W. C Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134, 2139-2147.
  • 9Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A.; Knauer, S. K.; Bantz, C.; Nawroth, T.; Bier, C.; Sirirattanapan, J. et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACSNano 2011, 5, 7155-7167.
  • 10Dell'Orco, D.; Lundqvist, M.; Oslakovic, C.; Cedervall, T.; Linse, S. Modeling the time evolution of the nanoparticle- protein corona in a body fluid. PloS One 2010, 5, e10949.

共引文献2

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部